Lastly, patients with heart failure (HF), composite cardiovascular events (i.e., unstable angina, ischemic heart disease, myocardial infarction, coronary stenting, percutaneous coronary intervention (PCI), coronary artery bypass), and clinically significant portal hypertension events (i.e., esophageal varices with and without bleeding, ascites, hepatic failure, hepatorenal syndrome, portal hypertension, liver transplant status, fibrosis, sclerosis and cirrhosis of the liver, hepatic encephalopathy, jaundice) were excluded if they occurred before inclusion to the cohort or prior to the index event
A Phase 2 clinical trial published in the New England Journal of Medicine (2023) reported substantial reductions in body weight and improvements in metabolic markers, generating considerable interest
Have already began lowering his insulin without testing
Polewski, M
Localized hypoxia within the subgranular zone determines the early survival of newborn hippocampal granule cells